Clinical trial Recruiting at 1 site Interventional Ages 52 to 67

Volumetric visual fields with progressive lenses for presbyopia at intermediate and near distances

Official title: Ensayo clínico, unicéntrico, Transversal, Randomizado, Cruzado, Doble Ciego Para Evaluar Las Diferencias de Los Campos volumétricos de visión en Distancia Intermedia (4m) y Cerca (25cm) de Tres Tipos de Lentes oftálmicas de adición Progresiva (PAL), Dos de visión Intermedia y Cerca (PC-PAL) y Otra Generalista de Vision Lejos, Intermedia y Cerca (GPPAL), Neutros en Vision de Lejos y de 2.00 D en Vision de Cerca en Pacientes présbitas.

Run by University of Seville · NCT07617090 · Data updated 2026-11-12

Researchers will test two occupational progressive lenses to see which provides a larger clear field at intermediate and near distances for people with presbyopia.

Quick facts

Study typeInterventional
Ages52 Years to 67 Years
SexAll
Enrollment26 (estimated)
SponsorUniversity of Seville
Academic / other
Locations2 sites (Seville, Andalusia and 1 other locations)
StatusRecruiting
StartedSeptember 29, 2025
Main results expectedNovember 28, 2025
Study endsOctober 31, 2026
Registry record updatedOctober 15, 2026
Trial IDNCT07617090 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults with presbyopia who meet specific refractive criteria (distance ≤ ±4.00 D, astigmatism ≤ 1.00 D), adequate distance-vision acuity, and stable ocular motility.

Probably not a fit

Patients with higher astigmatism, prior cataract or intraocular lens surgery, progressive contact lens wear, significant anisometropia, or compromised ocular motility may not benefit from these lenses.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a single-center, randomized, double-blind, crossover trial comparing two occupational progressive lenses designed for intermediate and near vision in presbyopic adults. Participants will undergo a series of optometric evaluations and visual field assessments while wearing each lens type, with a fixed head position during testing. The study uses plano distance power and a +2.00 D near addition to measure differences in the extent and depth of clear vision across multiple working distances. Outcomes focus on volumetric visual fields and how they vary between lens options under standardized conditions.

Why it matters

Potential benefit: If successful, one lens option may provide a larger or deeper clear visual field for tasks at intermediate and near distances, potentially improving functional vision for presbyopic patients.

How similar studies have gone: Previous work with progressive addition lenses has shown variable benefits; this study explores volumetric visual fields to provide deeper insight beyond standard acuity measurements.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Spherical ametropia for distance vision ≤ ±4.00 D and astigmatic ametropia ≤ 1.00 D.
* Decimal VA ≥ 0.8, either uncorrected (UCVA) or corrected (BCVA) with monofocal contact lenses.
* Patients with a nasopupillary distance (NPD) of 31 mm, with a tolerance of ±2 mm in each eye

Exclusion Criteria:

* Astigmatism greater than ±1.00 D.
* Patients wearing progressive contact lenses.
* Patients who have undergone cataract surgery or have monofocal or multifocal intraocular lenses.
* Anisometropia greater than 2.50 D.
* Decimal distance visual acuity \< 0.8 (UCVA or BCVA) with monofocal contact lenses.
* Patients without normal ocular motility or with partial dysfunction of one or more ex-traocular muscles, or with restricted visual fields or scotomas.
* Visual suppression in one eye between 4 m and 25 cm.
* Strabismus or nystagmus.

Where it's running

  • Phaculty of Pharmacy, University of Seville
    Seville, Andalusia, Spain
    Recruiting
  • Pharmacy school, University of Seville
    Seville, Sevilla, Spain
    Active not recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.